Various medicinal activities have been observed in a diverse range of molecules containing the quinazoline moiety, including but not limited to antifungal, antiviral, antidiabetic, anticancer, anti-inflammatory, antibacterial, antioxidant, and other activities. Quinazoline derivatives have been synthesized specifically for medicinal purposes such as antimalarial and anticancer agents.

Drug Structure Target Drug Categories
Gefitinib EGFR Antineoplastic Agents

Related Intermediates:

Related Products:

Drug Structure Target Drug Categories
Lapatinib EGFR Antineoplastic Agents

Related Intermediates:

Related Products:

Drug Structure Target Drug Categories
Erlotinib EGFR Antineoplastic Agents

Related Intermediates:

Related Products:

Drug Structure Target Drug Categories
Afatinib ErbB Antineoplastic Agents

Related Products:

Example Reaction of Piperidines:

More >

Categories:

See also:

References:

[1]Ravez S, Castillo-Aguilera O, Depreux P, et al. Quinazoline derivatives as anticancer drugs: a patent review (2011–present)[J]. Expert opinion on therapeutic patents, 2015, 25(7): 789-804.

[2]Wang D, Gao F. Quinazoline derivatives: synthesis and bioactivities[J]. Chemistry Central Journal, 2013, 7: 1-15.

[3]Selvam T P, Kumar P V. Quinazoline marketed drugs[J]. Research in Pharmacy, 2015, 1(1).

[4]Ahmad I. An insight into the therapeutic potential of quinazoline derivatives as anticancer agents[J]. MedChemComm, 2017, 8(5): 871-885.